N@N

MIPI, RAH, WPI, DVA, RAI. Top Gainers With Lowest Price Friction In Morning Trade Today

^{Published on 2009-06-17 08:14:05, Last Modified on 2010-12-22 14:14:31 - WOPRAI}
 

June 17, 2009 / M2 PRESSWIRE / BUYINS.NET, www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for June 17, 2009. Since late October market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This fair market making requirement is designed to prevent market makers from manipulating stock prices. Here is a list of the top companies with the largest gains this morning and lowest price friction (bullish). This means that there was more buying than selling in the stocks and their stock prices rose faster with less Friction. Molecular Insight Pharmaceuticals (NASDAQ: MIPI), Ralcorp Holdings (NYSE: RAH), Watson Pharmaceuticals (NYSE: WPI), DaVita (NYSE: DVA) and Reynolds American (NYSE: RAI). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .

Market Maker Friction Factor is shown in the chart below:

Symbol Change % BuyVol Buy% SellVol Sell% NetVol Friction

MIPI $1.59 36.31% 176,055 49.16% 163,246 45.58% 12,809 81

RAH $1.48 2.49% 15,900 55.16% 8,424 29.23% 7,476 51

WPI $1.45 5.03% 189,410 55.47% 113,420 33.22% 75,990 524

DVA $1.39 3.01% 24,500 54.81% 12,000 26.85% 12,500 90

RAI $1.12 3.08% 127,682 53.62% 63,764 26.78% 63,918 571

Click here to view chart:

Analysis of the Friction Factor chart above shows that each of the six stocks mentioned above have high net dollar gains (Change) and very low price friction in their stocks. The Friction Factor displays how many more shares of buying than selling are required to move a stock higher by one cent or how many more shares of selling than buying moves a stock lower by 1 cent.

For example, the chart above shows MIPI with a dollar gain today of +$1.59 and a Friction Factor of 81 shares. That means that it only takes 81 more shares of buying than selling to move MIPI higher by one penny. The Market Makers are currently allowing the stock to rise quickly (low friction). The combination of low friction and positive market direction can drive prices higher much faster than normal.

Molecular Insight Pharmaceuticals, Inc. (NASDAQ: MIPI), a development stage biopharmaceutical company, engages in the research, development, and commercialization of molecular imaging pharmaceuticals and radiotherapeutics primarily in the areas of oncology and cardiology in the United States. The company develops Zemiva, a molecular imaging pharmaceutical product, which completed Phase II clinical trail for the diagnosis of cardiac ischemia or insufficient blood flow to the heart; and Trofex, a preclinical trail product for the detection of metastatic prostate cancer. Its molecular radiotherapeutic oncology product candidates under development include Azedra that completed Phase I clinical trail for the treatment of pheochromocytoma in adults and neuroblastoma in children; Onalta, a Phase II clinical trail product for the treatment of metastatic carcinoid and pancreatic neuroendocrine tumors; and Solazed, a preclinical trail product for the treatment of malignant metastatic melanoma. The company was formerly known as Biostream, Inc. and changed its name to Molecular Insight Pharmaceuticals, Inc. in 2003. Molecular Insight Pharmaceuticals was founded in 1997 and is based in Cambridge, Massachusetts.

Ralcorp Holdings, Inc. (NYSE: RAH), through its subsidiaries, engages in the manufacture, distribution, and marketing of store brand (private label) food products in the grocery, mass merchandise, drug, and foodservice channels. The company�s products include ready-to-eat and hot cereal products; snack mixes and corn-based snacks; crackers and cookies; foodservice, frozen griddle products (pancakes, waffles, French toast, and custom griddle products), and biscuits; breads, rolls, and muffins; wet-filled products, such as salad dressings, mayonnaise, peanut butter, syrups, jams and jellies, and specialty sauces; and snack nuts and chocolate candy. It also holds an interest of approximately 19 percent in Vail Resorts, Inc., a mountain resort operator in the United States. Ralcorp Holdings serves retail chains, mass merchandisers, grocery wholesalers, warehouse club stores, drug stores, restaurant chains, and foodservice distributors in the United States and Canada. It sells its products through a broker network, internal sales staff, a network of third party warehouses, and independent truck lines. The company was founded in 1995 and is based in St. Louis, Missouri.

Watson Pharmaceuticals, Inc. (NYSE: WPI), a specialty pharmaceutical company, engages in the development, manufacture, marketing, sale, and distribution of generic and brand pharmaceutical products primarily in the United States. The company�s products are used in various therapeutic areas, including central nervous system, hormones and synthetic substitutes, cardiovascular, nephrology, gastrointestinal, and other areas. It operates in three segments: Generic, Brand, and Distribution. The Generic segment manufactures and sells generic products for various therapeutic classes comprising anti-depressant, anti-hypertensive, anti-diabetic, antiemetic, anti-hypertensive, analgesic, oral contraceptives, analgesic, and gastrointestinal areas, as well as for osteoporosis preparation and aid to smoking cessation. The Brand segment principally offers products for male hormone replacement, hematinic, overactive bladder, and prostate cancer therapeutics, as well as specialty products for urology and nephrology products for the treatment of iron deficiency anemia. The Distribution segment distributes generic and brand pharmaceutical products to independent pharmacies; alternate care providers, such as hospitals, nursing homes, and mail order pharmacies; pharmacy chains; physicians� offices; and members of buying groups. The company markets its products primarily to drug wholesalers; retailers and distributors, including national retail drug and food store chains; hospitals; clinics; mail order; and government agencies and managed healthcare providers, such as health maintenance organizations and other institutions. As of December 31, 2008, Watson Pharmaceuticals marketed approximately 150 generic pharmaceutical product families and 27 brand pharmaceutical product families, as well as distributed approximately 8,000 stock-keeping units. The company was founded in 1983 and is based in Corona, California.

DaVita Inc. (NYSE: DVA) provides dialysis services for patients suffering from chronic kidney failure, which is known as end stage renal disease (ESRD) in the United States. The company operates kidney dialysis centers, and provides related medical services primarily in dialysis centers and in contracted hospitals. Its services include outpatient dialysis services; hospital inpatient dialysis services; and ESRD laboratory services. The company also offers infusion therapy services; DaVita Rx, pharmacy that offers oral medications to patients with ESRD; vascular access services; disease management services and special needs plans; physician services; and clinical research programs. As of December 31, 2008, it operated or provided administrative services to 1,449 outpatient dialysis centers located in 43 states and the District of Columbia, serving approximately 112,000 patients. The company also provided acute inpatient dialysis services in approximately 700 hospitals and related laboratory services. DaVita Inc. was founded in 1994 and is headquartered in El Segundo, California.

Reynolds American Inc. (NYSE: RAI), through its subsidiaries, manufactures cigarettes and other tobacco products in the United States. It offers cigarettes under the CAMEL, KOOL, PALL MALL, DORAL, WINSTON, SALEM, MISTY, and CAPRI brands, as well as under the DUNHILL, STATE EXPRESS 555, and NATURAL AMERICAN SPIRIT brands. The company also manufactures other tobacco products, including little cigars under the WINCHESTER and CAPTAIN BLACK brands; roll-your-own tobacco under the BUGLER brand; and moist snuff under the GRIZZLY and KODIAK brands. In addition, Reynolds American offers loose leaf chewing tobacco, dry snuff, and plug and twist tobacco products. It sells its products primarily through distributors, wholesalers, and other direct customers, including retail chains, as well as distributes cigarettes to public warehouses. The company was founded in 1875 and is headquartered in Winston-Salem, North Carolina.

About BUYINS.NET

WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.

BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted. The SqueezeTrigger database of nearly 2,550,000,000 short sale transactions goes back to January 1, 2005 and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005 because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.

The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month�s short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money and a short squeeze can begin.

All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. None of the companies in this report have paid to be included in this report. From time to time we will mention a company that may have previously paid $995 per month for market data purchased from BUYINS.NET. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

BUYINS.NET, FRICTION FACTOR and SQUEEZETRIGGER are intended for use by stock market professionals. As a member, visitor, or user of any kind, you accept full responsibilities for your investment and trading actions. The contents of BUYINS.NET, including but not limited to all implied or expressed views, opinions, teachings, data, graphs, opinions, or otherwise are not predictions, warranty, or endorsements of any kind. Please seek stock market advice from the proper securities professional, or investment advisor.

By visiting BUYINS.NET or using any data or services, you agree to assume full responsibility for the decisions or actions that you undertake. BUYINS.NET, LLC, its owner(s), operators, employees, partners, affiliates, advertisers, information providers and any other associated person or entity, shall under no circumstances be held liable to the user and/or any third party for loss or damages of any kind, including but not limited to trading losses, lost trading opportunity, direct, indirect, consequential, special, incidental, or punitive damages. As a user, you agree that any damages collected shall not exceed the amount paid to BUYINS.NET and/or its owners. As a website user, you agree that any and all legal matters of any kind are to be reviewed and handled in their entirety within the State of California only. By using the services of this website, you are consenting to the terms as outlined, and forfeit all legal jurisdictions in any other State.

Past performance is not a guarantee of future outcomes. Any and all examples are hypothetical and should not be considered a guarantee or endorsement of such trading activity. BUYINS.NET does not take responsibility for problems of any kind, including but not limited to issues with operations, data accuracy or completeness, contacting issues, technical issues, and timeliness. BUYINS.NET places great integrity on the data collected and distributed. This information is deemed reliable, but not guaranteed. All information and data is provided "as is" without warranty or guarantee of any kind.

Please seek investment and/or trading advice, council, information or services from a securities professional. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.

This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the SEC.

Contact: Thomas Ronk, CEO www.BUYINS.net +1-800-715-9999 Tom@buyins.net